Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Articles published by Meitheal Pharmaceuticals, Inc.
Meitheal Pharmaceuticals to Present New Data in Infectious Disease Portfolio at IDWeek 2025
October 20, 2025
From
Meitheal Pharmaceuticals, Inc.
Via
Business Wire
Meitheal Pharmaceuticals Announces Appointment of Dr. Keith Robinson as Chief Medical Officer and Expansion of Medical Affairs Operation
July 31, 2025
From
Meitheal Pharmaceuticals, Inc.
Via
Business Wire
Meitheal Pharmaceuticals Announces Launch of Generic Paclitaxel Formulation in the United States Through Exclusive Commercial Licensing Agreement
May 29, 2025
From
Meitheal Pharmaceuticals, Inc.
Via
Business Wire
Meitheal Pharmaceuticals Announces Approval and Launch of Liraglutide Injection in the United States
April 03, 2025
From
Meitheal Pharmaceuticals, Inc.
Via
Business Wire
Meitheal Pharmaceuticals Grows Specialty Biopharmaceuticals Portfolio with Exclusive Commercial Licensing Agreement for XENLETA® (lefamulin acetate)
December 11, 2024
From
Meitheal Pharmaceuticals, Inc.
Via
Business Wire
Meitheal Pharmaceuticals Secures Exclusive Commercial Licensing Agreement for Three Biosimilars in the U.S.
October 31, 2024
From
Meitheal Pharmaceuticals, Inc.
Via
Business Wire
Meitheal Pharmaceuticals Expands Specialty Biopharmaceuticals Portfolio with Acquisition of CONTEPO™ (Fosfomycin for Injection) from Nabriva Therapeutics
July 18, 2024
From
Meitheal Pharmaceuticals, Inc.
Via
Business Wire
Meitheal Pharmaceuticals Strengthens Biologics Portfolio with an Exclusive Commercial Licensing Agreement for YUSIMRY®, a Biosimilar of Humira®
June 27, 2024
From
Meitheal Pharmaceuticals, Inc.
Via
Business Wire
Meitheal Pharmaceuticals Announces Recent Business Progress Reinforcing Commitment to Sustainable Generics Development
March 19, 2024
From
Meitheal Pharmaceuticals, Inc.
Via
Business Wire
Meitheal Pharmaceuticals Joins Biosimilars Forum
October 17, 2023
From
Meitheal Pharmaceuticals, Inc.
Via
Business Wire
Meitheal Pharmaceuticals Announces Expansion of Portfolio of Generic Injectable Products
October 03, 2023
From
Meitheal Pharmaceuticals, Inc.
Via
Business Wire
Meitheal Announces Exclusive Commercial Licensing Agreement for Insulin Biosimilars in the U.S.
September 21, 2023
From
Meitheal Pharmaceuticals, Inc.
Via
Business Wire
Meitheal Announces Closing of Senior Secured Credit Facility Agreement for Up to $80 Million with J.P. Morgan
August 22, 2023
From
Meitheal Pharmaceuticals, Inc.
Via
Business Wire
Meitheal Pharmaceuticals Announces Findings from Collaborative Research Study with Premier Inc. Evaluating Anticoagulant Treatment of COVID-19 Patients
September 15, 2021
From
Meitheal Pharmaceuticals, Inc.
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.